Clinical Trial Update: Mechanistic Randomized Controlled Trial (RCT) of Mesalazine in Symptomatic Diverticular Disease [NA]

View source ↗

Summary

A completed randomized controlled trial evaluated mesalazine for symptomatic diverticular disease of the colon.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diverticular Disease of the Colon

Drugs mentioned

• Mesalazine (mesalazine)

Snippet

Sponsor: University of Nottingham | Conditions: Diverticulosis, Colonic | NA | Status: COMPLETED